Clinical efficacy of acupoint application therapy combined with Kangyou Decoction in treating Helicobacter pylori infection with damp-heat syndrome of the middle Jiao.

IF 2.5 3区 生物学
Shang-Ren Xie, Meng-Yi Lv, Jun Yang, Hai-Jing Chen, Jie-Ru Wu, Yao-Qi Xu, Jie Jin, Jian-Wei Jin
{"title":"Clinical efficacy of acupoint application therapy combined with Kangyou Decoction in treating Helicobacter pylori infection with damp-heat syndrome of the middle Jiao.","authors":"Shang-Ren Xie, Meng-Yi Lv, Jun Yang, Hai-Jing Chen, Jie-Ru Wu, Yao-Qi Xu, Jie Jin, Jian-Wei Jin","doi":"10.1186/s41065-025-00533-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study evaluated the clinical efficacy and safety of acupoint application of traditional Chinese medicine (TCM) combined with Kangyou Decoction in patients with Helicobacter pylori (Hp) infection presenting with damp-heat syndrome obstructing the middle jiao.</p><p><strong>Methods: </strong>A total of 416 patients with Hp infection and TCM-defined damp-heat syndrome of the middle jiao were enrolled and randomly assigned to a treatment group (n = 208) or a control group (n = 208). The control group received standard bismuth-containing quadruple therapy, while the treatment group received acupoint application of TCM combined with oral administration of Kangyou Decoction. Both groups underwent treatment for two weeks. Outcomes included Hp eradication rates, changes in TCM syndrome scores pre- and post-treatment, and the incidence of adverse reactions.</p><p><strong>Results: </strong>Following two weeks of therapy, no statistically significant difference in Hp eradication rates was observed between the two groups (p > 0.05). Both groups demonstrated significant improvement in TCM syndrome scores (p < 0.05), with the treatment group showing a greater reduction compared to the control group (p < 0.05). The total effective rate in the treatment group was higher than that in the control group. Incidences of adverse reactions did not differ significantly between the groups (p > 0.05).</p><p><strong>Conclusion: </strong>Acupoint application combined with Kangyou Decoction yielded comparable Hp eradication outcomes to bismuth quadruple therapy in patients with damp-heat syndrome of the middle jiao. The combined therapy demonstrated greater improvement in clinical symptoms with a favorable safety profile, supporting its potential for clinical application.</p>","PeriodicalId":12862,"journal":{"name":"Hereditas","volume":"162 1","pages":"157"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351774/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hereditas","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s41065-025-00533-1","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study evaluated the clinical efficacy and safety of acupoint application of traditional Chinese medicine (TCM) combined with Kangyou Decoction in patients with Helicobacter pylori (Hp) infection presenting with damp-heat syndrome obstructing the middle jiao.

Methods: A total of 416 patients with Hp infection and TCM-defined damp-heat syndrome of the middle jiao were enrolled and randomly assigned to a treatment group (n = 208) or a control group (n = 208). The control group received standard bismuth-containing quadruple therapy, while the treatment group received acupoint application of TCM combined with oral administration of Kangyou Decoction. Both groups underwent treatment for two weeks. Outcomes included Hp eradication rates, changes in TCM syndrome scores pre- and post-treatment, and the incidence of adverse reactions.

Results: Following two weeks of therapy, no statistically significant difference in Hp eradication rates was observed between the two groups (p > 0.05). Both groups demonstrated significant improvement in TCM syndrome scores (p < 0.05), with the treatment group showing a greater reduction compared to the control group (p < 0.05). The total effective rate in the treatment group was higher than that in the control group. Incidences of adverse reactions did not differ significantly between the groups (p > 0.05).

Conclusion: Acupoint application combined with Kangyou Decoction yielded comparable Hp eradication outcomes to bismuth quadruple therapy in patients with damp-heat syndrome of the middle jiao. The combined therapy demonstrated greater improvement in clinical symptoms with a favorable safety profile, supporting its potential for clinical application.

穴位贴敷法配合康优汤治疗幽门螺杆菌感染中焦湿热证的临床疗效观察。
背景:本研究评价中药穴位贴敷配合康优汤治疗幽门螺杆菌(Hp)感染湿热阻中焦的临床疗效和安全性。方法:选取416例Hp感染合并中医定义的中角湿热证患者,随机分为治疗组(n = 208)和对照组(n = 208)。对照组采用标准含铋四联疗法,治疗组采用中药穴位贴敷配合康油汤口服。两组均接受为期两周的治疗。结果包括Hp根除率、治疗前后中医证候评分变化及不良反应发生率。结果:治疗2周后,两组Hp根除率比较,差异无统计学意义(p < 0.05)。两组中医证候评分均有显著改善(p < 0.05)。结论:穴位贴敷配合康优汤治疗中焦湿热证的Hp根除效果与铋四联疗法相当。联合治疗对临床症状的改善更大,且具有良好的安全性,支持其临床应用的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hereditas
Hereditas Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.80
自引率
3.70%
发文量
0
期刊介绍: For almost a century, Hereditas has published original cutting-edge research and reviews. As the Official journal of the Mendelian Society of Lund, the journal welcomes research from across all areas of genetics and genomics. Topics of interest include human and medical genetics, animal and plant genetics, microbial genetics, agriculture and bioinformatics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信